Muddy Waters Shorts Japan Biotech PeptiDream; Shares Slump
- Short seller questions firm’s partnerships with drug firms
- Shares fall as much as 5.5% in Tokyo trading Thursday
This article is for subscribers only.
Muddy Waters said it’s short Japanese biotech stock PeptiDream Inc., sending the company’s shares sliding.
PeptiDream fell as much as 5.5% in Tokyo trading Thursday after the short seller questioned the level of activity at the company’s drug development partnerships with pharmaceutical companies. The stock ended the day 4% lower.